Published in World J Gastroenterol on January 14, 2011
Pancreatic neuroendocrine tumors: biology, diagnosis,and treatment. Chin J Cancer (2012) 0.95
Elusive liver factor that causes pancreatic α cell hyperplasia: A review of literature. World J Gastrointest Pathophysiol (2015) 0.75
Insulinoma or non-insulinoma pancreatogenous hypoglycemia? A diagnostic dilemma. J Surg Case Rep (2016) 0.75
Hyperinsulinemic hypoglycemia with nesidioblastosis after gastric-bypass surgery. N Engl J Med (2005) 6.88
Evaluation and management of adult hypoglycemic disorders: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab (2008) 4.68
Nesidioblastoma, the islet tumor of the pancreas. Am J Pathol (1938) 3.80
Lower blood glucose, hyperglucagonemia, and pancreatic alpha cell hyperplasia in glucagon receptor knockout mice. Proc Natl Acad Sci U S A (2003) 3.53
Severe hypoglycaemia post-gastric bypass requiring partial pancreatectomy: evidence for inappropriate insulin secretion and pancreatic islet hyperplasia. Diabetologia (2005) 3.10
Regulation of pancreatic beta-cell mass. Physiol Rev (2005) 2.66
A mouse model of multiple endocrine neoplasia, type 1, develops multiple endocrine tumors. Proc Natl Acad Sci U S A (2001) 2.57
Intrinsic regulators of pancreatic beta-cell proliferation. Annu Rev Cell Dev Biol (2006) 2.40
Molecular regulation of pancreatic beta-cell mass development, maintenance, and expansion. J Mol Endocrinol (2007) 2.12
Perspective: Postnatal pancreatic beta cell growth. Endocrinology (2000) 2.08
Noninsulinoma pancreatogenous hypoglycemia: a novel syndrome of hyperinsulinemic hypoglycemia in adults independent of mutations in Kir6.2 and SUR1 genes. J Clin Endocrinol Metab (1999) 2.06
Persistent hyperinsulinemic hypoglycemia in 15 adults with diffuse nesidioblastosis: diagnostic criteria, incidence, and characterization of beta-cell changes. Am J Surg Pathol (2005) 2.04
Hyperinsulinemic hypoglycemia after gastric bypass surgery is not accompanied by islet hyperplasia or increased beta-cell turnover. Diabetes Care (2006) 2.03
Signaling and transcriptional control of pancreatic organogenesis. Curr Opin Genet Dev (2002) 2.02
Neuroendocrine tumors of the pancreas. Oncologist (2009) 1.91
Genes, signals, and lineages in pancreas development. Annu Rev Cell Dev Biol (2003) 1.89
Beta cell differentiation during early human pancreas development. J Endocrinol (2004) 1.82
Microadenomatosis of the endocrine pancreas in patients with and without the multiple endocrine neoplasia type 1 syndrome. Am J Surg Pathol (2006) 1.71
Pancreatic polypeptide reduces appetite and food intake in humans. J Clin Endocrinol Metab (2003) 1.71
Reversible hyperinsulinemic hypoglycemia after gastric bypass: a consequence of altered nutrient delivery. J Clin Endocrinol Metab (2010) 1.66
Endocrine precursor lesions and microadenomas of the duodenum and pancreas with and without MEN1: criteria, molecular concepts and clinical significance. Pathobiology (2007) 1.65
Somatostatin secreted by islet delta-cells fulfills multiple roles as a paracrine regulator of islet function. Diabetes (2008) 1.61
Islet hyperplasia in adults: challenge to preoperatively diagnose non-insulinoma pancreatogenic hypoglycemia syndrome. World J Surg (2006) 1.55
Multiple endocrine neoplasia type 1 (MEN1): loss of one MEN1 allele in tumors and monohormonal endocrine cell clusters but not in islet hyperplasia of the pancreas. J Clin Endocrinol Metab (2006) 1.55
Gastric bypass and nesidioblastosis--too much of a good thing for islets? N Engl J Med (2005) 1.54
Multiple neuroendocrine tumors of the pancreas in von Hippel-Lindau disease patients: histopathological and molecular genetic analysis. Am J Pathol (1998) 1.51
Neuroendocrine tumors of the gastro-entero-pancreatic system. World J Gastroenterol (2008) 1.48
Glycemic control in mice with targeted disruption of the glucagon receptor gene. Biochem Biophys Res Commun (2002) 1.44
Clinical pathology of endocrine tumors of the pancreas. Analysis of autopsy cases. Dig Dis Sci (1991) 1.39
Inhibition of pancreas and gallbladder by pancreatic polypeptide. Lancet (1978) 1.39
The basic structural lesion of persistent neonatal hypoglycaemia with hyperinsulinism: deficiency of pancreatic D cells or hyperactivity of B cells? Diabetologia (1984) 1.35
Persistent hyperinsulinaemic hypoglycaemia of infancy: a heterogeneous syndrome unrelated to nesidioblastosis. Arch Dis Child Fetal Neonatal Ed (2000) 1.33
Noninsulinoma pancreatogenous hypoglycemia syndrome: an update in 10 surgically treated patients. Surgery (2000) 1.32
Diffuse and focal nesidioblastosis. A clinicopathological study of 24 patients with persistent neonatal hyperinsulinemic hypoglycemia. Am J Surg Pathol (1989) 1.24
Homozygous P86S mutation of the human glucagon receptor is associated with hyperglucagonemia, alpha cell hyperplasia, and islet cell tumor. Pancreas (2009) 1.22
MEN I pancreas: a histological and immunohistochemical study. World J Surg (1984) 1.12
Glucagon cell adenomatosis: a newly recognized disease of the endocrine pancreas. J Clin Endocrinol Metab (2008) 1.10
Clinical features and morphological characterization of 10 patients with noninsulinoma pancreatogenous hypoglycaemia syndrome (NIPHS). Clin Endocrinol (Oxf) (2006) 1.09
Reactive hypoglycemia. Endocrinol Metab Clin North Am (1989) 1.01
Endocrine precursor lesions of gastroenteropancreatic neuroendocrine tumors. Endocr Pathol (2007) 0.99
Pancreatic B-cell proliferation in persistent hyperinsulinemic hypoglycemia of infancy: an immunohistochemical study of 18 cases. Mod Pathol (1998) 0.98
Nesidioblastosis and hyperplasia of alpha cells, microglucagonoma, and nonfunctioning islet cell tumor of the pancreas: review of the literature. Pancreas (2008) 0.98
Postprandial reactive hypoglycemia. Diabetes Metab (2000) 0.93
Pancreatic polypeptide cell hyperplasia with and without watery diarrhea syndrome. J Surg Oncol (1980) 0.91
Focal and Diffuse Beta Cell Changes in Persistent Hyperinsulinemic Hypoglycemia of Infancy. Endocr Pathol (1999) 0.91
Hyperinsulinism in developmental syndromes. Endocr Dev (2009) 0.89
Nesidioblastosis with glucagon-reactive islet cell hyperplasia: a case report. Pancreas (2003) 0.89
Hyperinsulinemic hypoglycemia in adults with islet-cell hyperplasia and degranulation of exocrine cells of the pancreas. Am J Clin Pathol (1983) 0.88
Endocrine hyperplasia and dysplasia in the pathogenesis of gastrointestinal and pancreatic endocrine tumors. Gastroenterol Clin North Am (2007) 0.87
Histopathology of congenital hyperinsulinism: retrospective study with genotype correlations. Pediatr Dev Pathol (2003) 0.87
Highlights of the biology of endocrine tumours of the gut and pancreas. Endocr Relat Cancer (2003) 0.87
Alpha cell hyperplasia in calcific pancreatitis associated with hyperparathyroidism. JAMA (1967) 0.86
Adult pancreatic nesidioblastosis. Unusual presentations of a rare entity. Arch Surg (1994) 0.86
Prevalence of diffuse pancreatic beta islet cell disease with hyperinsulinism: problems in recognition and management. World J Surg (1984) 0.86
When the usual insulin is just not enough. Proc Natl Acad Sci U S A (2007) 0.85
Pancreatic endocrine microadenomatosis in patients with von Hippel-Lindau disease: characterization by VHL/HIF pathway proteins expression. Am J Surg Pathol (2009) 0.84
Pancreatic-polypeptide cell hyperplasia associated with pancreatic or duodenal gastrinomas. Hum Pathol (1997) 0.84
Islet cell hyperplasia of the pancreas presenting as hyperinsulinemic hypoglycemia in an adult. Yonsei Med J (2000) 0.82
Pancreatic polypeptide hyperplasia causing watery diarrhea syndrome: a case report. Can J Surg (1999) 0.82
The role of ATP sensitive channels in insulin secretion and the implications in persistent hyperinsulinemic hypoglycaemia of infancy (PHHI). Adv Exp Med Biol (2007) 0.80
Histologic findings in persistent hyperinsulinemic hypoglycemia of infancy: Australian experience. Pediatr Dev Pathol (2000) 0.79
Pathogenesis of gastrinomas associated with multiple endocrine neoplasia type 1. Gut (2007) 0.78
Hypoglycemia and insular hyperplasia: review of 148 cases. Ann Surg (1974) 0.77
Indium-111 pentetreotide uptake by pancreatic polypeptide cell hyperplasia: potential pitfall in somatostatin receptor scintigraphy. Pancreas (2007) 0.77
Cystic glucagonoma: A rare variant of an uncommon neuroendocrine pancreas tumor. J Gastrointest Surg (1999) 0.76
Pancreatic polypeptide cell hyperplasia of the pancreas. J Clin Pathol (2006) 0.76
Rare presentation of endocrine pancreatic tumor: a case of diffuse glucagonoma without metastasis and necrolytic migratory erythema. J Formos Med Assoc (2005) 0.76
Islet-cell hyperplasia causing hyperinsulinemic hypoglycemia in an adult. J Gastroenterol (1998) 0.76
Pathologic classification and clinical behavior of the spectrum of goblet cell carcinoid tumors of the appendix. Am J Surg Pathol (2008) 2.27
TL1A (TNFSF15) regulates the development of chronic colitis by modulating both T-helper 1 and T-helper 17 activation. Gastroenterology (2008) 2.06
Is nonsmall cell type high-grade neuroendocrine carcinoma of the tubular gastrointestinal tract a distinct disease entity? Am J Surg Pathol (2008) 1.54
S100P, von Hippel-Lindau gene product, and IMP3 serve as a useful immunohistochemical panel in the diagnosis of adenocarcinoma on endoscopic bile duct biopsy. Hum Pathol (2010) 1.51
Homozygous P86S mutation of the human glucagon receptor is associated with hyperglucagonemia, alpha cell hyperplasia, and islet cell tumor. Pancreas (2009) 1.22
Pituitary tumor transforming gene-null male mice exhibit impaired pancreatic beta cell proliferation and diabetes. Proc Natl Acad Sci U S A (2003) 1.19
Genome wide analysis and clinical correlation of chromosomal and transcriptional mutations in cancers of the biliary tract. J Exp Clin Cancer Res (2009) 1.12
Senescence mediates pituitary hypoplasia and restrains pituitary tumor growth. Cancer Res (2007) 1.09
Mixed acinar-endocrine carcinoma of the pancreas: new clinical and pathological features in a contemporary series. Pancreas (2013) 1.06
Murine model of Hirschsprung-associated enterocolitis. I: phenotypic characterization with development of a histopathologic grading system. J Pediatr Surg (2010) 1.04
Pancreatic neuroendocrine tumors in glucagon receptor-deficient mice. PLoS One (2011) 1.02
Nesidioblastosis and hyperplasia of alpha cells, microglucagonoma, and nonfunctioning islet cell tumor of the pancreas: review of the literature. Pancreas (2008) 0.98
Ki-67 proliferative index predicts progression-free survival of patients with well-differentiated ileal neuroendocrine tumors. Hum Pathol (2011) 0.98
Murine model of Hirschsprung-associated enterocolitis II: Surgical correction of aganglionosis does not eliminate enterocolitis. J Pediatr Surg (2010) 0.97
Pancreatic neuroendocrine tumors: biology, diagnosis,and treatment. Chin J Cancer (2012) 0.95
A novel corrective pullthrough surgery in a mouse model of Hirschsprung's disease. J Pediatr Surg (2009) 0.94
Goblet or signet ring cells: that is the question. Adv Anat Pathol (2009) 0.90
Diminished pancreatic beta-cell mass in securin-null mice is caused by beta-cell apoptosis and senescence. Endocrinology (2009) 0.89
B lymphocyte-induced maturation protein-1 contributes to intestinal mucosa homeostasis by limiting the number of IL-17-producing CD4+ T cells. J Immunol (2012) 0.88
Testicular mixed germ cell tumors: a morphological and immunohistochemical study using stem cell markers, OCT3/4, SOX2 and GDF3, with emphasis on morphologically difficult-to-classify areas. Mod Pathol (2009) 0.87
Enterocolitis causes profound lymphoid depletion in endothelin receptor B- and endothelin 3-null mouse models of Hirschsprung-associated enterocolitis. Eur J Immunol (2015) 0.87
Splenic lymphopenia in the endothelin receptor B-null mouse: implications for Hirschsprung associated enterocolitis. Pediatr Surg Int (2011) 0.87
Clinical utility of FDG-PET for diagnosis of adrenal mass: a large single-center experience. Hormones (Athens) (2013) 0.86
Functional association of somatostatin receptor subtypes 2 and 5 in inhibiting human growth hormone secretion. J Clin Endocrinol Metab (2003) 0.86
The cell adhesion molecules N-cadherin and neural cell adhesion molecule regulate human growth hormone: a novel mechanism for regulating pituitary hormone secretion. J Clin Endocrinol Metab (2003) 0.84
Application of immunohistochemistry to liver and gastrointestinal neoplasms: liver, stomach, colon, and pancreas. Arch Pathol Lab Med (2008) 0.84
Dietary galactose inhibits GDF-9 mediated follicular development in the rat ovary. Reprod Toxicol (2005) 0.83
Left ventricular thrombus and embolic stroke caused by a functional paraganglioma. J Clin Hypertens (Greenwich) (2009) 0.83
Diagnosis and treatment of pheochromocytoma in an academic hospital from 1997 to 2007. Am J Med (2009) 0.82
Value of Islet 1 and PAX8 in identifying metastatic neuroendocrine tumors of pancreatic origin. Mod Pathol (2012) 0.82
Interobserver and intraobserver variability in evaluating vascular invasion in hepatocellular carcinoma. J Gastroenterol Hepatol (2010) 0.82
Calcifying fibrous tumor: an unrecognized IgG4--related disease? APMIS (2014) 0.82
Expression of glypican-3 in undifferentiated embryonal sarcoma and mesenchymal hamartoma of the liver. Hum Pathol (2011) 0.82
FDG PET/CT as a prognostic test after 90Y radioembolization in patients with metastatic hepatic disease. Clin Nucl Med (2012) 0.82
Animal models and cell lines of pancreatic neuroendocrine tumors. Pancreas (2013) 0.81
HMPL-004 (Andrographis paniculata extract) prevents development of murine colitis by inhibiting T-cell proliferation and TH1/TH17 responses. Inflamm Bowel Dis (2013) 0.80
Nuclear imaging of neuroendocrine tumors with unknown primary: why, when and how? Eur J Nucl Med Mol Imaging (2015) 0.79
Pancreatic neuroendocrine tumors: presentation, management, and outcomes. Am Surg (2009) 0.79
Anti-aging therapy with human growth hormone associated with metastatic colon cancer in a patient with Crohn's colitis. Clin Gastroenterol Hepatol (2008) 0.78
Adjuvant treatment of early colon cancer with micrometastases: results of a national survey. J Surg Oncol (2012) 0.78
Radioembolization for treatment of liver metastases from neuroendocrine tumors: correlation with imaging and biomarkers. Pancreas (2013) 0.77
Transfection of pancreatic-derived beta-cells with a minigene encoding for human glucagon-like peptide-1 regulates glucose-dependent insulin synthesis and secretion. Endocrinology (2002) 0.77
α-Internexin: a novel biomarker for pancreatic neuroendocrine tumor aggressiveness. J Clin Endocrinol Metab (2014) 0.77
Clinical use and utility of metaiodobenzylguanidine scintigraphy in pheochromocytoma diagnosis. Endocr Pract (2010) 0.77
Differences and Similarities in the Clinicopathological Features of Pancreatic Neuroendocrine Tumors in China and the United States: A Multicenter Study. Medicine (Baltimore) (2016) 0.77
Comparison of PAX6 and PAX8 as immunohistochemical markers for pancreatic neuroendocrine tumors. Endocr Pathol (2015) 0.77
Glucagon cell adenomatosis without glucagon receptor mutation. Pancreas (2013) 0.77
Exocrine pancreas hyperplasia without dysplasia in glucagon receptor knockout mice. Pancreas (2014) 0.76
Radiotherapy: Radioactive somatostatin analog therapy against carcinoids. Nat Rev Endocrinol (2010) 0.76
A novel molecular marker of pituitary tumor transforming gene involves in a rat liver regeneration. J Surg Res (2005) 0.76
The cellular composition of osteoclastlike giant cell-containing tumors of the pancreatobiliary tree. Am J Surg Pathol (2008) 0.76
The immunohistochemical expression of islet 1 and PAX8 by rectal neuroendocrine tumors should be taken into account in the differential diagnosis of metastatic neuroendocrine tumors of unknown primary origin. Endocr Pathol (2013) 0.75
Intraductal Tubulopapillary Neoplasm of the Pancreas: A Clinicopathologic and Immunohistochemical Analysis of 33 Cases. Am J Surg Pathol (2016) 0.75
Concurrent primary hyperparathyroidism and humoral hypercalcemia of malignancy in a patient with multiple endocrine neoplasia type 1. Pancreas (2011) 0.75
Natural history of a sporadic pheochromocytoma. Endocr Pract (2008) 0.75
Bilateral pheochromocytoma manifesting as acute shortness of breath after job loss. Endocr Pract (2011) 0.75
Pheochromocytoma in patients suspected of harboring adrenal metastasis: management and clinical predictors. Endocr Pract (2008) 0.75
The Clinicopathological Aspects of Primary Presacral Neuroendocrine Neoplasms: One Center Experience. Pancreas (2017) 0.75
Diagnosis and management of pheochromocytoma in an academic hospital 3 years after formation of a pheochromocytoma interest group. Endocr Pract (2011) 0.75
VISUAL VIGNETTE. Endocr Pract (2016) 0.75
Ghost carcinoid in a patient with 120-fold elevated 5-hydroxyindoacetic acid. Endocr Pract (2012) 0.75
Smoothelin expression in the gastrointestinal tract: implication in colonic inertia. Appl Immunohistochem Mol Morphol (2013) 0.75
Internal jugular thrombus revealed by fine-needle aspiration to be metastatic papillary thyroid carcinoma. Endocr Pract (2011) 0.75
Morphologic features of carcinoid heart disease as assessed by three-dimensional transesophageal echocardiography. Echocardiography (2010) 0.75
Atypical de Quervain's thyroiditis masquerading as papillary thyroid cancer. Endocrinol Nutr (2012) 0.75
Visual Vignette. Endocr Pract (2015) 0.75
Humoral hypercalcemia of malignancy caused by parathyroid hormone-related peptide-secreting neuroendocrine tumors. Report of six cases. Pancreatology (2013) 0.75
Cardiac arrest in a patient with asthma: role of hemorrhagic pheochromocytoma discovered at autopsy. J Clin Hypertens (Greenwich) (2012) 0.75
Metabolic and receptor imaging in patients with neuroendocrine tumors: comparison of fludeoxyglucose-positron emission tomography and computed tomography with indium in 111 pentetreotide. Endocr Pract (2009) 0.75
Growth speed of sporadic pheochromocytoma. Clin Endocrinol (Oxf) (2012) 0.75
Subacute thyroiditis metamorphosing into Graves’ disease. Endocrinol Nutr (2014) 0.75
Unsuspected fluorodeoxyglucose positron emission tomography (FDG-PET)-positive pancreatic lesions: prevalence and significance. Pancreas (2013) 0.75
Spared adrenals: transient florid ectopic Cushing syndrome associated with necrosis of metastatic carcinoid. Endocr Pract (2010) 0.75
Adrenal Cushing syndrome shortly after adrenal insufficiency. Endocr Pract (2011) 0.75
The State of the Art in Colorectal Cancer Molecular Biomarker Testing. Adv Anat Pathol (2016) 0.75